Cite
Kamat SA, Offord S, Docherty J, et al. Reduction in inpatient resource utilization and costs associated with long-acting injectable antipsychotics across different age groups of Medicaid-insured schizophrenia patients. Drugs Context. 2015;4doi: 10.7573/dic.212267.
Kamat, S. A., Offord, S., Docherty, J., Lin, J., Eramo, A., Baker, R. A., Gutierrez, B., & Karson, C. (2015). Reduction in inpatient resource utilization and costs associated with long-acting injectable antipsychotics across different age groups of Medicaid-insured schizophrenia patients. Drugs in context, 4. https://doi.org/10.7573/dic.212267
Kamat, Siddhesh A, et al. "Reduction in inpatient resource utilization and costs associated with long-acting injectable antipsychotics across different age groups of Medicaid-insured schizophrenia patients." Drugs in context vol. 4 (2015). doi: https://doi.org/10.7573/dic.212267
Kamat SA, Offord S, Docherty J, Lin J, Eramo A, Baker RA, Gutierrez B, Karson C. Reduction in inpatient resource utilization and costs associated with long-acting injectable antipsychotics across different age groups of Medicaid-insured schizophrenia patients. Drugs Context. 2015 Mar 17;4. doi: 10.7573/dic.212267. eCollection 2015. PMID: 25834621; PMCID: PMC4376094.
Copy
Download .nbib